You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Efficacy and safety of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) monotherapy for advanced EGFR-mutated non-small cell lung cancer: systematic review and meta-analysis.
|
---|---|
Published in |
European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360, October 2021
|
DOI | 10.26355/eurrev_202110_26993 |
Pubmed ID | |
Authors |
H J Lee, G H Jeong, H Li, M S Kim, J S Kim, S J Park, Y J Han, K H Lee, A Kronbichler, S H Hong, R A Ghayda, C Luchini, A Nottegar, A Koyanagi, L Smith, L Jacob, E Dragioti, J Radua, S Cargnin, S Terrazzino, T Thompson, D K Yon, S W Lee, J M Yang, P Wasuwanich, J I Shin, G Gamerith |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 11 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 2 | 18% |
Student > Postgraduate | 2 | 18% |
Student > Bachelor | 2 | 18% |
Lecturer | 1 | 9% |
Researcher | 1 | 9% |
Other | 1 | 9% |
Unknown | 2 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 36% |
Unspecified | 2 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 9% |
Business, Management and Accounting | 1 | 9% |
Biochemistry, Genetics and Molecular Biology | 1 | 9% |
Other | 0 | 0% |
Unknown | 2 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2021.
All research outputs
#23,069,091
of 25,711,518 outputs
Outputs from European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360
#1,901
of 3,216 outputs
Outputs of similar age
#376,693
of 438,466 outputs
Outputs of similar age from European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] NLMUID: 9717360
#45
of 69 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,216 research outputs from this source. They receive a mean Attention Score of 3.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,466 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.